Anaptysbio ANAB
Anaptysbio, Inc · Nasdaq · Pharmaceutical Preparations
$50.50+1.75%close on Oct. 28, 2026 · volume 306K · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Oct. 1, 2026 | Hollings Renton director | Sold 10b5-1 plan | 5,000 | $49.87 | $249,372 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 8 →Financial statements and exhibits
Submission of matters to a vote of security holders · Financial statements and exhibits
Regulation FD disclosure